Abstract:Emerging evidence has demonstrated the critical roles for both androgen and Wnt pathways in prostate tumorigenesis. A recent integrative genomic analysis of human prostate cancers (PCas) has revealed a unique enrichment of androgen and Wnt signaling in early-onset PCas, implying their clinical significance in the disease. Additionally, interaction between the androgen receptor (AR) and β-catenin has long been detected in PCa cells. However, the consequence of this interaction in prostate tumorigenesis is still unknown. Because mutations in adenomatous polyposis coli, β-catenin and other components of the destruction complex are generally rare in PCas, other mechanisms of aberrant Wnt signaling activation have been speculated. To address these critical questions, we developed Ctnnb1(L(ex3)/+)/R26hAR(L/+):PB-Cre4 mice, in which transgenic AR and stabilized β-catenin are co-expressed in prostatic epithelial cells. We observed accelerated tumor development, aggressive tumor invasion and a decreased survival rate in Ctnnb1(L(ex3)/+)/R26hAR(L/+):PB-Cre4 compound mice compared with age-matched Ctnnb1(L(ex3)/+):PB-Cre4 littermate controls, which only have stabilized β-catenin expression in the prostate. Castration of the above transgenic mice resulted in significant tumor regression, implying an essential role of androgen signaling in tumor growth and maintenance. Implantation of the prostatic epithelial cells isolated from the transgenic mice regenerated prostate intraepithelial neoplasias and prostatic adenocarcinoma lesions. Microarray analyses of transcriptional profiles showed more robust enrichment of known tumor- and metastasis-promoting genes: Spp1, Egr1, c-Myc, Sp5, and Sp6 genes, in samples isolated from Ctnnb1(L(ex3)/+)/R26hAR(L/+):PB-Cre4 compound mice than those from Ctnnb1(L(ex3)/+):PB-Cre4 and R26hAR(L/+):PB-Cre4 littermate controls. Together, these data demonstrate a confounding role of androgen signaling in β-catenin-initiated oncogenic transformation in prostate tumorigenesis.

Human Homolog of Drosophila Hairy and Enhancer of Split 1, Hes1, Negatively Regulates Δ-Catenin (CTNND2) Expression in Cooperation with E2F1 in Prostate Cancer

δ-Catenin promotes prostate cancer cell growth and progression by altering cell cycle and survival gene profiles

E2F1 Renders Prostate Cancer Cell Resistant to ICAM-1 Mediated Antitumor Immunity by NF-κB Modulation.

Expression of Differentiation Associated Protein Hes1 and Hes5 in Cervical Squamous Carcinoma and Its Precursors.

The mitotic regulator Hec1 is a critical modulator of prostate cancer through the long non-coding RNA BX647187 in vitro.

Hes1/Hes5 Gene Inhibits Differentiation Via Down-Regulating Hash1 And Promotes Proliferation In Cervical Carcinoma Cells

Tensin 1 regulated by hepatic leukemia factor represses the progression of prostate cancer

Prognostic Significance of Hes-1, a Downstream Target of Notch Signaling in Hepatocellular Carcinoma.

HNF1B-mediated Repression of SLUG is Suppressed by EZH2 in Aggressive Prostate Cancer

High Frequency of HES1 Loss in Colorectal Adenocarcinomas with RAS/BRAF Mutations

Polycomb Protein Ezh2 Activates Wnt/Beta-Catenin Signaling To Promote Hepatocellular Carcinoma Development

Expression Pattern and Clinical Significance of Hairy Enhancer of Split 1 in Colorectal Cancer

Direct interaction of β-catenin with nuclear ESM1 supports stemness of metastatic prostate cancer

Altered Ets transcription factor activity in prostate tumor cells inhibits anchorage-independent growth, survival, and invasiveness

A Human- And Male-Specific Protocadherin That Acts Through The Wnt Signaling Pathway To Induce Neuroendocrine Transdifferentiation Of Prostate Cancer Cells

Integrative Analysis Reveals the Transcriptional Collaboration Between EZH2 and E2F1 in the Regulation of Cancer-Related Gene Expression

Transcription factor ETS1‑mediated ECT2 expression promotes the malignant behavior of prostate cancer cells

Clinical Significance of Hepsin and Underlying Signaling Pathways in Prostate Cancer

Androgen signaling is a confounding factor for β-catenin-mediated prostate tumorigenesis

Hes1 Controls Proliferation and Apoptosis in Chronic Lymphoblastic Leukemia Cells by Modulating PTEN Expression

Transcription Repressor Hes1 is a Selective Regulator of TLR-induced CXCL1 Expression and Neutrophil Responses (IRM5P.708)